tiprankstipranks
Purple Biotech Ltd. (IL:PPBT)
TASE:PPBT
Israel Market
PPBT
Purple Biotech
RESEARCH TOOLSreports

Purple Biotech (PPBT) Financial Statements

Compare
1 Followers

Purple Biotech Financial Overview

Purple Biotech's market cap is currently ₪18.58M. The company's EPS TTM is -4.1000000000000005; its P/E ratio is -0.13; Purple Biotech is scheduled to report earnings on February 11, 2026, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 195.80K$ 0.00$ 0.00
Gross Profit$ 0.00$ -62.00K$ -196.00$ -120.00$ -55.00
Operating Income$ -29.72M$ -11.01M$ -22.27M$ -22.60M$ -17.93M
EBITDA$ -29.72M$ -7.05M$ -19.88M$ -21.49M$ -17.52M
Net Income$ -28.79M$ -7.24M$ -19.88K$ -21.67M$ -18.38M
Balance Sheet
Cash & Short-Term Investments$ 9.58M$ 8.52M$ 15.41M$ 32.11M$ 47.20M
Total Assets$ 17.58M$ 37.04M$ 44.30M$ 54.62M$ 70.20M
Total Debt$ 244.05K$ 183.00K$ 351.00K$ 515.00K$ 749.00K
Net Debt$ -8.47M$ -7.22M$ -14.14M$ -14.52M$ -10.14M
Total Liabilities$ 7.91M$ 4.13M$ 10.01M$ 7.52M$ 5.09M
Stockholders' Equity$ 9.72M$ 32.86M$ 34.21M$ 46.91M$ 64.83M
Cash Flow
Free Cash Flow$ -5.95M$ -14.37M$ -19.93M$ -16.96M$ -15.19M
Operating Cash Flow$ -5.95M$ -14.37M$ -19.93M$ -16.73M$ -15.07M
Investing Cash Flow$ 482.78K$ 509.00K$ 13.88M$ 19.91M$ 13.41M
Financing Cash Flow$ 6.88M$ 6.77M$ 5.45M$ 1.11M$ 1.51M
Currency in USD

Purple Biotech Earnings and Revenue History

Income Statement >

Purple Biotech Debt to Assets

Balance Sheet >

Purple Biotech Cash Flow

Cash Flow >

Purple Biotech Forecast EPS vs Actual EPS

Earnings >